GIANFILIPPO, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 220
EU - Europa 83
AS - Asia 27
AF - Africa 18
SA - Sud America 2
Totale 350
Nazione #
US - Stati Uniti d'America 219
IT - Italia 23
SE - Svezia 22
BG - Bulgaria 15
SG - Singapore 11
CI - Costa d'Avorio 8
DE - Germania 8
CN - Cina 6
GB - Regno Unito 6
NG - Nigeria 6
VN - Vietnam 5
AT - Austria 3
PL - Polonia 3
SN - Senegal 3
BR - Brasile 2
HK - Hong Kong 2
IN - India 2
DO - Repubblica Dominicana 1
EG - Egitto 1
FI - Finlandia 1
FR - Francia 1
NL - Olanda 1
TR - Turchia 1
Totale 350
Città #
Chandler 44
Fairfield 33
Seattle 22
Sofia 15
Ashburn 13
Woodbridge 11
Wilmington 9
Abidjan 8
Cambridge 8
New York 8
Florence 7
Beijing 6
Frankfurt am Main 6
Houston 6
Lagos 6
Lawrence 6
Medford 6
Princeton 6
Ann Arbor 4
London 4
Pisa 4
Dakar 3
Singapore 3
Vienna 3
Bremen 2
Dallas 2
Dong Ket 2
Hong Kong 2
Kolkata 2
Los Angeles 2
Polska 2
Redwood City 2
Cairo 1
Carrara 1
Daly City 1
Denver 1
Diemen 1
Diyarbakir 1
Freitas 1
Helsinki 1
Newton-le-willows 1
Reston 1
San Francisco 1
Santo Domingo Este 1
Silver Spring 1
Warsaw 1
Totale 271
Nome #
Circulating biomarkers of response to immunotherapy in cancer treatment 69
Erratum: Clinical pharmacology of monoclonal antibodies targeting PD-1 axis in urothelial cancers 64
Endothelial nitric oxide synthase c.-813C>T predicts for proteinuria in metastatic breast cancer patients treated with bevacizumab-based chemotherapy 61
Incidence of T790M in Patients With NSCLC Progressed to Gefitinib, Erlotinib, and Afatinib: A Study on Circulating Cell-free DNA 61
Clinical pharmacology and drug-drug interactions of lenvatinib in thyroid cancer 56
Clinical pharmacology of monoclonal antibodies targeting anti-PD-1 axis in urothelial cancers 49
Totale 360
Categoria #
all - tutte 1.549
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.549


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202054 0 0 0 0 0 8 12 10 10 3 8 3
2020/202169 0 6 3 7 13 3 12 2 8 3 3 9
2021/202260 2 3 0 2 11 9 2 0 5 5 5 16
2022/2023137 17 20 9 8 19 16 0 9 29 0 10 0
2023/202440 5 4 8 3 6 8 1 3 0 2 0 0
Totale 360